- Investing Ideas
- Australian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Australian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
2
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
2 companies
BLS Pharmaceuticals
Market Cap: AU$186.3m
Manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czech Republic, and Japan.
BLS
AU$0.81
7D
-3.6%
1Y
74.2%
Cann Group
Market Cap: AU$4.2m
Engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe.
CAN
AU$0.0025
7D
-16.7%
1Y
-83.3%